C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 167/130,
C12N 15/38 (2006.01) A61K 39/245 (2006.01) C07K 14/045 (2006.01) C07K 16/08 (2006.01) C12Q 1/70 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)
Patent
CA 1340832
The present invention provides recombinant polypeptides derived from CMV glycoprotein gB and truncated fragments thereof which contain at least one epitope which is immunologically identifiable with one encoded by the CMV genome. The complete characterization of the gB protein, including the identity of glycoprotein gp55, permits the production of polypeptides which are useful as standards or reagents in diagnostic tests and/or as components of vaccines. This invention provides recombinant polypeptides and recombinant polynucleotides encoding these polypeptides wherein a neutralizing epitope of gB is localized within gp55.
589457
Pachl Carol A.
Spaete Richard R.
Aventis Pasteur
Borden Ladner Gervais Llp
Chiron Corporation
LandOfFree
Recombinant cmv neutralizing proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant cmv neutralizing proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant cmv neutralizing proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1226258